These findings provide mechanistic insight into the differential roles of ESE1 in regulating different cell malignant properties and offer a potential explanation for its seemingly contradicting impact on RFS and OS in PDAC patients, as well as some early conflicting results reported in different types of cancer. Here, ELF3 is linked to cancer.